Monthly Archives: April 2012

Featured Stories

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed.

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Nursing Homes Overprescribing Antipsychotic Drugs

Nursing homes are overprescribing antipsychotic drugs, according to government figures. The strong, sedating drugs, as we’ve long written, are often used on nursing home patients who are agitated and combative. A Boston Globe investigation, which involved data collected 19 months … Continue reading

Posted in Legal News, Nursing Home Abuse, Pharmaceuticals | Tagged |

Environmental Group ID’s 28 Coal Ash Pollution Sites

An environmental advocacy group has identified at least 28 coal fly ash dump sites, previously unrecognized by federal regulators, responsible for contaminating groundwater and posing serious public health risks. According to a report at Care2.com, the Environmental Integrity Project has … Continue reading

Posted in Health Concerns, Toxic Substances | Tagged |

FDA Issues Warning Letters to Makers of DMAA Workout Boosters

The U.S. Food & Drug Administration (FDA) just issued warning letters to the makers of DMAA workout boosters, challenging the marketing of DMAA dietary supplement products for lack of safety evidence. The FDA cited 10 companies that manufacture and distribute … Continue reading

Posted in Legal News, Pharmaceuticals | Tagged , |

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on … Continue reading

Posted in Actos, Pharmaceuticals | Tagged |

Kawasaki Recalls Off-Highway Vehicles for Crash Risk

Kawasaki has issued a recall of off-highway vehicles for crash risk, said the U.S. Consumer Product Safety Commission (CPSC). The recall involves about 2,000 Teryx Recreational Off-Highway Vehicles, which were manufactured in the United States; distributed by Kawasaki Motors Corp., … Continue reading

Posted in Defective Products, Motor Vehicles, Product Recalls, Recalled Vehicles | Tagged |

Deadly SUV Accident at Bronx Zoo Under Investigation

This weekend’s deadly SUV accident at New York City’s Bronx Zoo is under investigation. All seven people in the SUV died. Authorities are trying to understand why the vehicle drove off the highway, jumped a guardrail, and crashed—upside down—on zoo … Continue reading

Posted in Accident |

Cancer Conference Attendees Call for More Independent Study of Cell Phone – Brain Cancer Link

Calling the tremendous growth in cell phone use the “biggest experiment of our species,” attendees at a scientific conference held in London last week have called for more independent research into the possible connection between cell phones and brain cancer. … Continue reading

Posted in Cell Phones & Cancer, Cellular Phone | Tagged |

Accretive Health Facing Scrutiny for Questionable Debt Collection Tactics at Hospitals

A debt collection agency is facing scrutiny for the heavy handed tactics it employs at some hospitals around the country. According to a report from The New York Times, Accretive Health, the nation’s largest collectors of medical debt, is facing … Continue reading

Posted in Consumer Fraud | Tagged |

Recalls Issued for Dangerous Rattles, Sippy Cups

Two recalls have been issued for dangerous rattles and sippy cups, government agencies just announced. A recall involving Whoozit® Starry Time Rattle was announced jointly by the U.S. Consumer Product Safety Commission (CPSC) and Health Canada (HC). The Target Home … Continue reading

Posted in Product Recalls | Tagged |

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke. Two recent studies … Continue reading

Posted in Defective Medical Devices | Tagged |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.